DR. DANIEL MARTIN SCHREEDER MD PHD NPI 1457650848

NPI Details

DR. Daniel Martin Schreeder, MD, PHD is a hematology and oncology internal medicine in Huntsville, AL with 14 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Daniel Martin Schreeder, MD, PHD NPI is 1457650848. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE
Graduation Year:2011

The provider's business location address is:

3601 CCI DR NW
HUNTSVILLE, AL
ZIP 35805-606
Phone: (256) 705-4224

The NPI 1457650848 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, levoleucovorin (khapzory), 0.5 mg (HCPCS:J0642)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, ferric derisomaltose, 10 mg (HCPCS:J1437)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg (HCPCS:Q5118)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, atropine sulfate, 0.01 mg (HCPCS:J0461)
• Injection, pegfilgrastim-apgf, biosimilar, (nyvepria), 0.5 mg (HCPCS:Q5122)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Injection, iron dextran, 50 mg (HCPCS:J1750)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Nephelometry, test method using light (HCPCS:83883)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Iron level (HCPCS:83540)
• Magnesium level (HCPCS:83735)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron binding capacity (HCPCS:83550)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Phosphate level (HCPCS:84100)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Unclassified drugs (HCPCS:J3490)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Protein measurement, serum (HCPCS:84165)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Injection of drug or substance into vein (HCPCS:96374)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Automated urinalysis test (HCPCS:81003)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Uric acid level, blood (HCPCS:84550)
• Reticulated (young) platelet measurement (HCPCS:85055)
• Folic acid level, serum (HCPCS:82746)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Administration of chemotherapy into vein using push technique (HCPCS:96409)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Translocation analysis (bcr/abl1) major breakpoint (HCPCS:81206)
• Translocation analysis (bcr/abl1) minor breakpoint (HCPCS:81207)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
• Vitamin d-3 level (HCPCS:82306)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Gene analysis (janus kinase 2) variant (HCPCS:81270)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Stool analysis for blood, by fecal hemoglobin determination by immunoassay (HCPCS:82274)
• Erythropoietin (protein) level (HCPCS:82668)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)

The enumeration date for this NPI number is 3/24/2011 and was last updated on 1/27/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: